An Observational Study on The Safety and Effectiveness of Mabthera (Rituximab) in The First Six Months of Treatment in Patients With Severe Active Rheumatoid Arthritis



Status:Archived
Conditions:Arthritis, Rheumatoid Arthritis
Therapuetic Areas:Rheumatology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:January 2010
End Date:February 2012

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Prospective, Multi-center Non-interventional Observational Study to Evaluate the Safety and Effectiveness of MabThera® (Rituximab) Within the First 6 Months of Treatment in Patients With Severe Active Rheumatoid Arthritis in Routine Care.


This prospective observational study will evaluate the safety and effectiveness of Mabthera
(Rituximab) within the first 6 months of treatment in patients with severe active rheumatoid
arthritis in routine care. For each eligible patient data will be collected for 6 months.
Target sample size is < 2000 patients.



We found this trial at
1
site
Trial Information Support Line
South San Francisco, California
?
mi
from
South San Francisco, CA
Click here to add this to my saved trials